Browse > Article

Effects of Microbacterium laevaniformans Levans Molecular Weight on Cytotoxicity  

Oh, Im-Kyung (Department of Food and Nutrition, Hanyang University)
Yoo, Sang-Ho (Department of Food Science and Technology, Sejong University)
Bae, In-Young (Department of Food and Nutrition, Hanyang University)
Cha, Jae-Ho (Department of Microbiology, Pusan National University)
Lee, Hyeon-Gyu (Department of Food and Nutrition, Hanyang University)
Publication Information
Journal of Microbiology and Biotechnology / v.14, no.5, 2004 , pp. 985-990 More about this Journal
Abstract
Levans produced from Microbacterium laevaniformans were isolated, characterized, and fractionated by molecular weight. TLC, HPLC, and GC-MS analyses of the exopolysaccharide showed that it was a fructan-type polymer and was composed of (2,6)- and (2,1)-glycosidic linkages. $^{13}C$-NMR analysis proved that the polysaccharide was mainly a $\beta$-(2,6)-linked levan-type polysaccharide. To investigate the cytotoxicity of the acetone-precipitated levan fractions such as M1, M2, and M3, HepG2, P388D1, U937, SNU-1, and SNUC2A cell lines were screened. Among the cell lines tested, the cytotoxicity of M1- M3 fractions were detected from only SNU-1 and HepG2 cells at the dosage level of $100-800\mu\textrm{g}ml$. The M2 fraction M_r$, 80,000) at 400 $mu{g/ml}$ had the greatest cell growth inhibition (84.6%) on SNU-1, while the M1 $(M_r$, 50,000) at $800\mu\textrm{g}ml$ showed the greatest (46.32%) on HepG2. To obtain more uniform M_r$ fractions of levan, the levan was further fractionated from S1 $(M_r$ 1,000,000) to S5 $(M_r$ 10,000) using gel permeation chromatography. Again, the S1-S5 fractions had strong cytotoxicity on SNU-1 and HepG2 cell lines. The greatest inhibition effects of S4 $(M_r$ 80,000) on SNU-1 and S5 $(M_r$ 10,000) on HepG2 were shown to be 49.5% and 73.0%, respectively. The cytotoxicity of the levan fractions was more effective on SNU-1 than on HepG2. Although the relationship between the Mw and the cytotoxicity was not clear, smaller $M_r$, fractions of levan showed greater growth inhibition effect on the cancer cell lines in general. Therefore, it was indicated that a specific Mw class of levan is responsible for the effective cytotoxicity.
Keywords
Levan; cytotoxicity; Microbacterium laevaniformans; molecular weight;
Citations & Related Records

Times Cited By Web Of Science : 2  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Allen, P. Z. and W. H. Bowen. 1990. Immunochemical studies on levans from several strains of Actinomyces viscosus. Archs. Oral Bioi. 35: 35- 62.
2 Carmichael, J., W. G. Degraff, A. F. Gazdar, J. D. Minna, and J. B. Michell. 1987. Evaluation of a tetrazolium based semiautomated colorimetric assay, assessment of chemosensitivity testing. Cancer Res. 47: 936- 940.
3 Han, Y. W. and M. A. Watson. 1992. Production of microbial levan from sucrose, sugarcane juice, and beet molasses. J. Ind. Microbiol. 9: 257-260.
4 Whiting, G. and R. Coggins. 1967. Levan formation of Acetomonas. J. Inst. Brew. 73: 422- 425.
5 Leibovici, J., S. Kopel, A. Siegel, and O. Gal-Mor. 1986. Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes. Int. J. Immunopharmacol. 8: 391- 403.
6 Calazans, G. M. T., C. E. Lopes, F. P. Francisca, and R. C. Lima. 1997. Antitumour activities of levans produced by Zymomonas mobilis strains. Biotechnol. Lett. 19: 19- 21.
7 Calazans, G. M. T., R. C. Lima, F. P. Francisca, and C. E. Lopes. 2000. Molecular weight and antitumor activity of Zymomonas mobilis. Int. J. Biol. Macromol. 27: 245- 247.
8 Newbrun, E. and S. Baker. 1968. Physico-chemical characteristics of the levan produced by Streptococcus salivarius. Carbohydr: Res. 6: 165- 170.
9 Rosell, K. G. and D. Birkhed. 1974. An inulin-like fructan produced by Streptococcus mutans, strain JC2. ACTA Chem. Scand. 28: 589-592.
10 Otterlei, M., A. Sundan, G. Skjak-Braek, L. Ryan, O. Smidsrod, and T. Espevik. 1993. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: Characterization of binding and tumor necrosis factor alpha induction. Infect. lmmun. 61: 1917- 1925.
11 Stark, Y. and J. Leibovici. 1986. Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma. Br. J. Exp. Pathol. 67: 141-147.
12 Rolf, D. and G. Gray. 1982. Analysis of the linkage positions in D-fructofuranosyl residues by the reductive cleavage method. J. Am. Chem. Soc. 104: 3539-3541.
13 Allen, P.Z. and E. A. Kabat. 1957. Studies on the capacity of some polysaccharides to elicit antibody formation to man. J. Exptl. Med. 105: 383- 394.
14 Yamada, H. 1996. Contribution of pectins on health care, pp. 173- 190. In J. Visser and A. G. J. Voragen (eds.). Pectins and Pectinases.
15 Euzenat, O., A. Guibert, and D. Combes. 1997. Production of fructo-oligosaccharides by levansucrase from Bacillus subtilis C4. Proc. Biochem. 32: 237- 243.   DOI   ScienceOn
16 Hakomori, S. J. 1964. A rapid permethylation of glycolipid polysaccharide catalyzed by methyl sulfonyl carbon ion dimethyl sulfoxide. Biochemistry 55: 205- 208.
17 Han, Y. W. and M. A. Clarke. 1990. Production and characterization of microbial levan. J. Agric. Food Chem. 38: 393- 396.
18 Jang, K-H., S. A. Kang, Y. Cho, Y.-Y. Kim, Y.-J. Lee, K. Hong, K.-H. Seong, S. H. Kim, C.-H. Kim, S.-K Rhee, S.-D. Ha, and R. Choue. 2003. Prebiotic properties of levan in rats. J. Microbiol. Biotech. 13: 348- 353.
19 Kim, H., H. Park, M. Kim, H. G. Lee, J. Yang, and J. Chao 2003. Enzymaticcharacterization of a recombinantlevansucrase from Rahnella aquatilis ATCC 15552. J. Microbiol. Biotech. 13: 230- 235.
20 Simms, P. J., W. J. Boyko, and J. R. Edwards, 1990. The structure analysis of a levan produced by Streptococcus salivarius SS2. Carbohydr. Res. 208: 193- 198.
21 Feingold, D. S. and M. Gehata. 1957. The structure and property of levan, a polymer of d-fructose produced by cultures and cell-free extract of Aerobacter levanicum. J. Poly. Sci. 22: 783- 790.
22 Han, Y. W. 1990. Microbial levan. Adv. Appl. Microbiol. 35: 171-194.   DOI   PUBMED
23 Johnes M. R., P. F. Greenfield, and H. W. Dolle. 1991. By-products from Zymomonas mobilis. Adv. Biochem. Eng. Biotechnol. 44: 97-- 101.